Rhythm Pharmaceuticals Inc. (RYTM)
NASDAQ · Healthcare
Rhythm Pharmaceuticals Inc. Gross Profit 2016–2025
Rhythm Pharmaceuticals Inc. annual/quarterly gross profit history and growth rate from 2021 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Rhythm Pharmaceuticals Inc. gross profit for the quarter ending March 31, 2026 was 53.0 M, a 82.25% increase year-over-year.
- Rhythm Pharmaceuticals Inc. gross profit for the twelve months ending March 31, 2026 was 170.8 M, a 72.83% increase year-over-year.
- Rhythm Pharmaceuticals Inc. annual gross profit for 2025 was 170.3 M, a 45.83% increase from 2024.
- Rhythm Pharmaceuticals Inc. annual gross profit for 2024 was 116.8 M, a 71.39% increase from 2023.
- Rhythm Pharmaceuticals Inc. annual gross profit for 2023 was 68.1 M, a 216.79% increase from 2022.
- Rhythm Pharmaceuticals Inc. annual gross profit for 2022 was 21.5 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rhythm Pharmaceuticals Inc. Gross Profit — FAQ
Rhythm Pharmaceuticals Inc. (RYTM) gross profit over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Rhythm Pharmaceuticals Inc.'s gross profit?
Rhythm Pharmaceuticals Inc. (RYTM) reported gross profit of $170M for fiscal 2025.
Where can I see RYTM's gross profit history?
The chart and table above show Rhythm Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.